pharma · Hypertension
Innovent Biologics
Innovent Biologics (Suzhou) Co.
Innovent Biologics (Suzhou) is a pharma organization headquartered in CN. Primary therapeutic focus areas include Hypertension. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to thi
Suzhou, CN HQ
2011 Founded
850 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Suzhou, CN
- Founded
- 2011
- Employees
- 850
- Programs
- 2
- Drugs
- 3
- Patents
- 0
IBI3016
Phase 2 · small molecule · Hypertension
IBI3016 for Hypertension is a Phase 2 program (small_molecule) at Innovent Biologics (Suzhou) Co. with 2 ClinicalTrials.gov record(s).
Internal code CIBI3016A201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Innovent Biologics (Suzhou) Co.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Hypertension
- Status
- active
- Trials
- 2